Antibody raised against the human erythrocyte glucose transporter identified a recombinant Xgtll bacteriophage in a cDNA library prepared from immunoselected polysomal RNA from adult rat brain. The cDNA predicts a 492-amino acid protein that demonstrates 97.6% identity to the human hepatoma hexose carrier. The tissue distribution of the transporter mRNA is identical to that of immunologically identifiable protein and transport activity, except in liver in which high levels of transport are associated with little or no transporter mRNA or protein. As assayed by blot-hybridization analysis, mRNA from insulin-responsive and nonresponsive tissues are indistinguishable. These data suggest that a genetically unrelated protein is responsible for hexose transport in normal liver.
Virtually all mammalian cell plasma membranes contain a system for the stereospecific transport of glucose (1). However, different cell types have at least several functionally distinguishable transport systems with properties consistent with their tissue distribution. In the brush border membranes of kidney and small intestines, which transfer glucose from luminal compartments into the circulation, the transporter is a sodium-dependent active carrier, in contrast to the facilitated transport system present in nonepithelial cells (1) . These two transport proteins are also immunologically distinguishable (2) . The passive carrier, of which the human erythrocyte protein has been best studied, is stimulated by insulin in specialized tissues (e.g., fat and skeletal muscle). However, there is no evidence for intrinsic differences in the transporter proteins of insulin-responsive and nonresponsive cells (1) . The structural basis of these differences in transporter function is a problem of considerable interest.
The human erythrocyte glucose-transporter protein is a heterogeneously glycosylated protein of Mr 55,000 (3) . The proteins present in rat adipose tissue and cultured mouse fat cells are about the same size and are related immunologically (4, 5) . Both murine and human mRNA code for a glucosetransporter protein whose primary translation product is Mr 38,000 as assayed by in vitro translation or metabolic labeling in the presence of an inhibitor of N-linked glycosylation (5) . Since polyclonal antisera prepared against the human erythrocyte glucose transporter recognized the nonglycosylated rat protein (unpublished observations) as well as the mature protein on immunoblots (4, 5) , it seemed that the antibody might be a useful tool for obtaining the cDNA for the rat glucose transporter. This report describes the primary structure of such a cDNA clone, its remarkable sequence homology to the human glucose transporter (6) , and the indication of a genetically unrelated transport system active in human and rat liver.
MATERIALS AND METHODS
Materials. Avian myeloblastosis virus reverse transcriptase was from Life Sciences Construction and Screening of a cDNA Library. RNA was prepared by guanidinium isothiocyanate (Fluka) disruption of cells and centrifugation through 5.7 M cesium chloride (7), with further purification by oligo(dT)-cellulose chromatography (8) . mRNA was translated by using a wheat germ system (9) .
Total adult brain polysomes were prepared as described except that the initial homogenization buffer contained 1% Triton X-100 and 1% sodium deoxycholate and the polysomes were stored at -70°C in buffer containing 500 units of RNasin (Promega Biotec) per ml (10) . Immunoadsorption and elution of RNA was by the method of Shapiro and Young (11) .
cDNA was constructed by oligo(dT) priming of the first strand and self priming of the second strand with cleavage of the hairpin loop by mung bean nuclease (12) . The doublestranded cDNA was fractionated by 4% polyacrylamide gel electrophoresis, and all material with mobility slower than a 1.3-kilobase (kb) standard was electroeluted. This material was concentrated by precipitation with ethanol and inserted in Xgtll, which was then packaged and used to infect E. coli Y1090 (12) . The library was screened with rabbit antisera, and the second antibody-biotin system (ABC) of Vector Laboratories (Burlingame, CA). Positive clones were plaquepurified twice, from which DNA was prepared (ref. 13 , pp. 371-372) and subcloned into pUC19 (14) . Restriction fragAbbreviation: kb, kilobase(s). *To whom correspondence should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 5785 ments were cloned into M13 mpl8 or M13 mpl9 and sequenced by the dideoxy chain termination technique (15 (17) . Highstringency hybridization was as described above. Lowstringency conditions were the same except that the hybridization solution contained 25% formamide and the blots were washed at room temperature.
RESULTS
Preparation and Screening of an Enriched cDNA Library. Screening normal rat tissues for glucose transporter mRNA by in vitro translation and immunoprecipitation (5) revealed that rat brain was a relatively abundant source of transporter mRNA. In vitro translation of poly(A)+ RNA from rat brain showed a product of Mr 38,000 and an apparently lessabundant species ofMr =58,000 (Fig. 1, lane 1) . The presence of nonradioactive human erythrocyte transporter during treatment with antibody completely interfered with precipitation of the Mr 38,000 protein but only partially competed with the larger polypeptide for antibody (Fig. 1 , lane 2). As described previously, the Mr 38,000 species represents the primary translation product of the glucose-transporter protein (5). Total polysomes were prepared from adult rat brain and enriched for glucose-transporter mRNA by using rabbit 1 15 positive signals, all of which were found to cross-hybridize. DNA was prepared from these, and the largest insert of about 1.9 kb was subcloned into pUC19 to give prGTH-14. The insert was sequenced and the 5' end was used to make a probe with which to rescreen the amplified Xgtll library by nucleic acid hybridization. Thus, a bacteriophage containing a 2.6-kb insert was identified, and the cDNA was cloned into the EcoRI site of pUC19 to give prGT4-12.
Deduced Primary Structure of the Rat Brain Glucose Transporter. The nucleotide sequence and deduced amino acid sequence of the rat brain glucose transporter is shown in Fig.  2 . It represents the complete sequence of the insert in prGTH-14 as well as the 5' 800 base pairs of the insert in prGT4-12. The remainder of the two cDNAs were identical, based on analysis with multiple restriction enzymes. There is a single long open reading frame extending from nucleotide 208 to 1683 that predicts a 492-amino acid protein of Mr 56,133. The discrepancy between the deduced molecular mass and apparent Mr of the transporter and its anomalous behavior on polyacrylamide gel electrophoresis have been noted (5, 6) . Comparison of the rat sequence to that predicted from a cDNA obtained from a library prepared from a human hepatoma cell line (HepG2) (6) indicated identity at 97.6% of amino acid residues. Of the few amino acid differences, most were conservative substitutions (Fig. 2) .
A comparison of the rat brain and human hepatoma noncoding sequence is shown in Fig. 3 . The homology between the nucleotide sequence, which is about 89% in the coding region, extends only partly into the 5' untranslated region. The nucleotide homology is 78% over the 36 nucleotides immediately adjacent to the putative ATG initiation codon, and there is essentially no homology in the 5'-most sequence available for comparison. On the other hand, the 3' untranslated regions show strong homology from the putative termination codon to the polyadenylylation site in the rat cDNA. At this point the sequences diverge, the human cDNA extending for at least 300 additional nucleotide pairs. The sequence ATATAAA, which closely resembles the proposed consensus sequence for termination (19) , is located about 20 nucleotides upstream from the putative poly(A) addition site in the rat cDNA and is present in the human sequence. Three additional rat brain cDNAs were sequenced at their 3' ends and found to have the same terminal sequence as the insert from prGTH-14 (data not shown).
Structure of the Glucose-Transporter Gene. Southern blot analysis of high molecular weight DNA isolated from rat brain after cleavage with three different restriction enzymes revealed a simple pattern consistent with the presence of a single gene (Fig. 4) . A similarly prepared blot showed an identical hybridization pattern when probed at low stringency; this is strong evidence against the presence of other unique sequences related to the transporter cDNA in the rat genome.
Tissue Distribution of Glucose-Transporter mRNA. Blothybridization analysis of total RNA from rat brain revealed a single hybridizing species of 2.9 kb (Fig. 5A, lane 1 (20) , had levels of-transporter that were less than brain levels by only a factor of 2-3 (Fig. 5A) . The disparity between transporter mRNA levels in adult rat brain (and liver was also true for 10-day-old rats (Fig. SB) . In both cases, the presence of intact liver RNA was verified by reprobing the blots with a rat albumin cDNA probe (data not shown).
Enrichment of mRNA by oligo(dT)-celiulose selection confirmed the presence of relatively small amounts of transporter mRNA in rat liver (Fig.. 5C ). Two micrograms of poly(A)+ RNA from brain (lane 1) or Fao cells (lane 5) produced a much stronger hybridization signal than did 10 ,ug of poly(4) liver RNA. By using scanning densitometry, it was estimated that in poly(A)+ RNA, glucose transporter mRNA was less abundant in liver than in Fao cells and brain by factors of 14 and 40, respectively. Fig. 5D shows a blot-hybridization of total RNA from several additional tissues; rat brain, adipose tissue, and kidney all contained a 2.9-kb transcript, the latter two in sligltly lower abundance, which hybridized to the transporter cDNA.
It was important to correlate the tissue differences in transporter mRNA levels with immunologically identifiable protein. As assayed by immunoblotting, no glucose-transporter protein was detected in rat liver membranes under conditions that readily demonstrated transporter of the appropriate electrophoretic mobility in membranes from rat brain and Fao cells (Fig. 6 ). There was no detectable transporter protein in normal human liver in spite of substantial amounts in IlepG2 membranes (Fig. 6 ). HepG2 cells contain glucose transporter mRNA levels similar to that in rat brain when blot-hybridizations were probed at moderately high stringency with the rat cDNA probe; no transporter mRNA has been detected in RNA prepared from normal human liver, though it has been difficult to obtain human hepatic RNA completely free of degradation (data not shown). The two species present in rat brain (Fig. 6, lane 6 as great as in the 3' flanking region except immediately adjacent to the putative ATG initiation codon.
Nontransformed rat liver cells possess a high-capacity sugar carrier with the unique function of physiological bidirectional transport. Glucose is taken up into hepatocytes after feeding and released during starvation. Liver transporter is similar to that in nonhepatic tissue in terms of substrate and inhibitor specificity (25) , though the two exhibit quantitative differences in the kinetics of transport and the binding of cytochalasin B (3, 26, 27) . The present data suggest that the hepatic glucose transporter is immunologically and genetically unrelated (or distantly related) to the transporter protein from brain, fat, kidney, fibroblasts, and hepatoma cells, all of which are at present indistinguishable by any structural criteria with the exception of glycosylation (5) . While it is possible that the relatively small amount of transporter mRNA detected by blot-hybridization analyses of liver (Fig.  SC) represents low levels of the transcript in hepatocytes, it is more likely that this is contributed by the nonhepatocyte cells comprising up to 10% of the mass of the adult rat liver (28) . It is presently unknown whether the presence of glucose transporter (as detected with the current probes) in HepG2 cells and Fao cells is caused solely by oncogenic transformation or instead by some change in cell function resulting from the establishment of continually growing cell lines. However, transporter mRNA levels in rat liver do not change during liver regeneration after partial hepatectomy (unpublished observation).
Finally, the availability of a cDNA probe corresponding to the rat glucose-transporter mRNA has provided tools with which to study the structure of the protein in insulin responsive and nonresponsive tissue. At least at the level of resolution of blot-hybridization analysis, the mRNA from a typically insulin-sensitive organ, adipose tissue, is indistinguishable from that expressed in brain and kidney (Fig. 5D ). This does not preclude the existence of different mRNAs of
